Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BEAT Insider Trading

BEAT | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at BEAT provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-12-23 01:44 2025-12-17 STROME MARK E 10% owner SELL $3.58 250,000 $895,000 2,900,000 -7.9%
2025-12-20 01:10 2025-12-17 de Urioste George Director SELL $3.19 57,146 $182,090 0 -100.0%
2025-02-22 04:00 2025-02-14 Ferrari Richard Director BUY $1.70 29,412 $50,000 179,136 +19.6%
2025-02-22 03:55 2025-02-14 Cruickshank Tim Officer - CFO BUY $1.70 17,647 $30,000 17,647 +100.0%
2024-09-11 23:36 2024-09-06 de Urioste George Director SELL $2.34 1,674 $3,917 57,146 -2.8%
2024-09-05 01:25 2024-08-30 de Urioste George Director SELL $2.31 5,500 $12,705 58,820 -8.6%
2024-08-29 23:18 2024-08-27 de Urioste George Director SELL $2.26 2,194 $4,958 64,320 -3.3%
2024-08-27 22:07 2024-08-23 de Urioste George Director SELL $2.31 2,800 $6,464 66,514 -4.0%
2023-10-04 02:18 2023-09-29 de Urioste George Director SELL $2.06 5,500 $11,330 36,129 -13.2%
2023-09-30 02:41 2023-09-27 de Urioste George Director SELL $2.05 9,834 $20,190 41,629 -19.1%
2023-09-27 19:01 2023-09-22 de Urioste George Director SELL $2.13 7,393 $15,738 51,463 -12.6%
2023-09-23 02:07 2023-09-20 de Urioste George Director SELL $2.45 983 $2,413 58,856 -1.6%
2023-09-20 01:51 2023-09-15 de Urioste George Director SELL $2.45 9,269 $22,674 59,839 -13.4%
2023-09-16 00:36 2023-09-13 de Urioste George Director SELL $2.05 10,000 $20,506 69,108 -12.6%
2021-12-24 01:59 2021-12-21 BROUNSTEIN RICHARD D Officer - Chief Financial Officer BUY $3.37 5,000 $16,846 102,075 +5.2%
2021-11-16 06:00 2021-11-11 BROUNSTEIN RICHARD D Officer - CHIEF FINANCIAL OFFICER BUY $5.99 5,000 $29,950 97,075 +5.4%
2021-11-16 05:59 2021-11-11 Ortigas-Wedekind Marga Director BUY $5.99 9,000 $53,910 16,824 +115.0%
2020-01-06 15:42 2019-12-31 Ferola Peter Officer - SVP & General Counsel OPT+S $46.62 5,065 $236,130 8,507 0.0%
2019-09-06 23:18 2019-09-04 Ferola Peter Officer - SVP & General Counsel OPT+S $39.03 44,276 $1,728,092 8,507 0.0%
2019-05-08 01:12 2019-05-03 GORMAN KIRK E Director OPT+S $53.69 5,518 $296,261 173,315 0.0%
2019-05-03 00:36 2019-04-30 GORMAN KIRK E Director OPT+S $54.37 5,518 $300,014 173,315 0.0%
2019-02-02 01:35 2019-01-31 Getz Heather C Officer - Executive VP & CFO OPT+S $70.41 10,590 $745,602 80,561 0.0%
2019-01-30 00:29 2019-01-25 Getz Heather C Officer - Executive VP & CFO OPT+S $70.06 93,383 $6,542,656 80,561 0.0%
2019-01-23 05:50 2019-01-17 Getz Heather C Officer - Executive VP & CFO OPT+S $70.01 8,236 $576,602 80,561 0.0%
2018-11-06 01:46 2018-11-01 RUBIN ROBERT J. Director OPT+S $60.36 8,489 $512,396 131,551 0.0%
2018-11-06 01:45 2018-11-01 Ferola Peter Officer - SVP & General Counsel OPT+S $60.61 75,000 $4,545,750 15,065 0.0%
2018-10-02 23:23 2018-09-28 Broadway Fred Officer - President BioTel Heart OPT+S $65.00 90,113 $5,857,345 24,880 0.0%
2018-10-02 23:23 2018-10-01 GORMAN KIRK E Director OPT+S $65.07 625 $40,669 173,315 0.0%
2018-09-20 00:13 2018-09-17 GORMAN KIRK E Director OPT+S $62.30 625 $38,938 173,315 0.0%
2018-09-06 00:13 2018-08-31 Wisniewski Daniel Officer - SVP, Technical Operations OPT+S $60.45 31,000 $1,873,950 26,291 0.0%
2018-07-31 00:26 2018-07-26 Capper Joseph H Director, Officer - President & CEO OPT+S $53.92 300,000 $16,176,240 178,355 0.0%
2018-07-26 01:53 2018-07-23 GORMAN KIRK E Director OPT+S $50.74 7,500 $380,550 173,315 0.0%
2018-07-03 23:49 2018-07-02 GORMAN KIRK E Director OPT+S $45.49 7,500 $341,175 173,315 0.0%
2018-06-14 01:05 2018-06-11 Capper Joseph H Director, Officer - President & CEO OPT+S $43.86 200,000 $8,772,120 178,355 0.0%
2018-06-02 01:14 2018-05-31 RIMEL REBECCA W Director OPT+S $42.28 9,338 $394,811 111,037 0.0%
2018-05-29 23:32 2018-05-24 RUBIN ROBERT J. Director OPT+S $42.00 5,000 $210,000 131,551 0.0%
2018-05-14 23:17 2018-05-11 Ferola Peter Officer - SVP & General Counsel OPT+S $40.42 67,370 $2,723,095 15,065 0.0%
2018-05-08 23:17 2018-05-07 Wisniewski Daniel Officer - SVP, Technical Operations OPT+S $41.09 40,000 $1,643,600 26,291 0.0%
2018-05-04 23:36 2018-05-02 Getz Heather C Officer - Executive VP & CFO OPT+S $39.62 36,405 $1,442,366 65,561 0.0%
2018-04-28 00:48 2018-04-26 Getz Heather C Officer - Executive VP & CFO OPT+S $38.03 65,570 $2,493,627 44,156 0.0%
2018-03-15 01:25 2018-03-13 Broadway Fred Officer - President BioTel Heart OPT+S $34.17 54,158 $1,850,579 24,880 0.0%
2017-05-17 00:30 2017-05-15 RUBIN ROBERT J. Director OPT+S $28.14 15,000 $422,100 149,047 0.0%
2017-03-22 23:14 2017-03-20 Broadway Fred Officer - SVP - Sales Marketing SELL $26.90 3,429 $92,240 25,420 -11.9%
2017-03-02 04:36 2017-02-27 Hrenko George Officer - SVP - Human Resources OPT+S $25.95 126,043 $3,270,816 20,518 0.0%
2017-03-02 04:35 2017-02-27 Hrenko George Officer - SVP - Human Resources OPT+S $25.97 19,642 $510,044 20,518 0.0%
2017-02-23 01:34 2017-02-21 Broadway Fred Officer - SVP - Sales Marketing SELL $24.81 8,070 $200,217 28,849 -21.9%
2016-09-20 23:01 2016-09-19 Broadway Fred Officer - SVP - Sales Marketing SELL $18.50 1,151 $21,294 36,735 -3.0%
2016-09-20 23:00 2016-09-19 Hrenko George Officer - SVP - Human Resources SELL $18.50 1,061 $19,629 37,568 -2.7%
2016-09-14 01:06 2016-09-13 Ferola Peter Officer - General Counsel OPT+S $18.23 4,352 $79,337 26,637 0.0%
2016-09-14 00:33 2016-09-13 Getz Heather C Officer - Chief Financial Officer SELL $18.23 5,866 $106,937 44,293 -11.7%
SHOW ENTRIES
1-50 OF 139

How to Interpret $BEAT Trades

Not every insider transaction in BEAT is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BEAT shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BEAT

Insider activity data for BEAT is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BEAT, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.